mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

Amaia Zabala-Letona1,2, Amaia Arruabarrena-Aristorena1, Natalia Martín-Martín1,2

  • 1CIC bioGUNE, Bizkaia Technology Park, 801 building, 48160, Derio, Spain.

Nature
|June 29, 2017
PubMed

Insights

The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates polyamine metabolism, crucial for cancer growth. This study reveals mTORC1 controls S-adenosylmethionine decarboxylase 1 (AMD1) stability, impacting cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Pathways

Background:

  • The PTEN-PI3K-mTORC1 pathway is critical for cancer cell growth and proliferation.
  • Polyamines are essential metabolites that support oncogenicity.

Purpose of the Study:

  • To investigate the role of mTORC1 in regulating polyamine metabolism in prostate cancer.
  • To identify specific molecular mechanisms linking mTORC1 to polyamine synthesis alterations.

Main Methods:

  • Integrative metabolomics analysis in a mouse model of prostate cancer.
  • Analysis of human prostate cancer biopsies.
  • Assessment of S-adenosylmethionine decarboxylase 1 (AMD1) stability and immunoreactivity.
  • Evaluation of samples from a clinical trial of an mTORC1 inhibitor.

Main Results:

  • mTORC1 regulates polyamine dynamics by controlling the stability of S-adenosylmethionine decarboxylase 1 (AMD1).
  • Tumors exhibit altered production of decarboxylated S-adenosylmethionine (dcSAM) and polyamine synthesis.
  • AMD1 is upregulated in human prostate cancer with activated mTORC1.
  • Treatment with an mTORC1 inhibitor (everolimus) decreased AMD1 levels and proliferation.

Conclusions:

  • mTORC1 integrates growth signals to promote an oncogenic metabolic program through polyamine regulation.
  • AMD1 stability is a novel regulatory point controlled by mTORC1, essential for dcSAM production and cancer cell growth.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
54
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.3K